DETOUR System for Leg Artery Blockages in Peripheral Arterial Disease
Observes the DETOUR System in people with peripheral arterial disease and long leg artery blockages.
Key facts
- Who runs it
- Endologix
- Where
- Boston, Cleveland, Delray Beach, Kansas City, New York, Salinas, Storrs, Washington D.C., West Chester, and Wynnewood, United StatesSee the 10 sites
- Trial code
- Registry title
- The Percutaneous Transmural Arterial Bypass -1 Study (Post Approval Registry)
- Status
- Enrolling by invitation
- People taking part
- 450 people, planned
- Started
- 6 Oct 2023
- Expected to end
- 7 Jun 2032
- Type of study
- Observational, 2 groups
- Treatments tested
- DETOUR System
- Record updated
- 12 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with peripheral arterial disease who have symptoms from blocked or narrowed arteries in the thigh and knee area. Their doctor must judge that they can be treated with the DETOUR System.
- Sex
- All sexes can join.
- Disease stage
- Symptomatic femoropopliteal lesions (thigh and knee arteries) from 200 mm to 460 mm long. These are either full long-term blockages (100 mm to 425 mm) or widespread narrowing of more than 70%. People may be poor candidates for surgery or other treatments done inside the blood vessels.
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- -
Who cannot take part
- -
Where in United States
- Beth Isreal Deaconess Medical CenterBoston, United StatesEnrolling by invitation
- Cleveland Clinic - Main CampusCleveland, United StatesEnrolling by invitation
- Delray Medical CenterDelray Beach, United StatesEnrolling by invitation
- Saint Luke's Hospital of Kansas CityKansas City, United StatesEnrolling by invitation
- NYU Langone Medical CenterNew York, United StatesEnrolling by invitation
- Salinas Valley Memorial HospitalSalinas, United StatesEnrolling by invitation
- University of ConnecticutStorrs, United StatesEnrolling by invitation
- MedStar Washington Hospital CenterWashington D.C., United StatesEnrolling by invitation
- University of PennsylvaniaWest Chester, United StatesEnrolling by invitation
- Main Line HealthWynnewood, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of this post-market surveillance study will be to evaluate the real-world use of the DETOUR System in treated patients with symptomatic femoropopliteal lesions from 200 mm to 460 mm in length with chronic total occlusions (100 mm to 425 mm) or diffuse stenosis > 70% who may be considered suboptimal candidates for surgical or alternative endovascular treatments.
The 2 groups in the trial
- As Treated
All patients that have received the therapy; patients treated within and outside the IFU criteria subgroups; male and female subgroups; and duplex imaging subgroups for arterial and venous observations.
Treatment: DETOUR System
- Imaging Cohort
Sites that are performing (arterial and venous) duplex ultrasound assessments according to the institution's standard practice will be asked to participate in the DUS imaging cohort. The Imaging sub-study will consist of 55 female and 55 male subjects from these sites. Duplex imaging at 1-, 12-, 24-, and 36-months post-procedure will be collected to assess the endpoints of graft patency and venous thrombus within the vein containing the graft (n=110).
Treatment: DETOUR System
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Prospective, Single Arm, Registry-based Study to Evaluate the Real-world Use of the DETOUR™ System in US Patients
- Plain-language title
- DETOUR System for Leg Artery Blockages in Peripheral Arterial DiseaseGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 May 2026